Phenazolam Explained
Phenazolam, (Clobromazolam, DM-II-90, BRN 4550445) is a benzodiazepine derivative which acts as a potent sedative and hypnotic drug. It was first invented in the early 1980s,[1] but was never developed for medical use. It has been sold over the internet as a designer drug, first being identified in seized samples by a laboratory in Sweden in March 2016.[2] [3]
Legality
Clobromazolam was made illegal in Serbia in May 2019,[4] and in Italy in March 2020.[5]
See also
Notes and References
- Polívka Z, Holubek J, Metyš J, Šedivŷ Z, Protiva M . Potential hypnotics and anxiolytics: 8-Chloro-6-(2-chlorophenyl)-1-[4-(2-methoxyethyl) piperazino]-methyl-4H-s-triazolo[4,3-a]-1,4-benzodiazepine and related compounds. . Collection of Czechoslovak Chemical Communications . 1983 . 48 . 12 . 3433–43 . 10.1135/cccc19833433 .
- Web site: Novel Benzodiazepines. A review of the evidence of use and harms of Novel Benzodiazepines. . Advisory Council on the Misuse of Drugs . April 2020 .
- Wagmann L, Manier SK, Felske C, Gampfer TM, Richter MJ, Eckstein N, Meyer MR . Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam . Journal of Analytical Toxicology . 45. 9. 1014–1027. October 2020 . 33048135 . 10.1093/jat/bkaa161 .
- Web site: "Службени гласник РС", број 38 од 31. маја 2019. . Serbian . Rulebook on determining the List of psychoactive controlled substances: 38 / 2019-121 . Serbian Ministry of Health .
- Web site: Legislazione - MINISTERO SALUTE - Decreto ministeriale . Italian . Legislation - MINISTRY HEALTH - Ministerial decree . 13 March 2020 .